Interactive Transcript
0:00
So here the take-home points from the session
0:03
on CT perfusion, I'd say number one
0:06
use non-con CT to guide your interpretation
0:09
of infarct core. The use
0:12
of CTP. CBF Maps is most helpful as
0:15
an adjunct for estimating the infarct core
0:18
in the late window of hyperacusro. That's
0:21
like 6 to 24 hours. I'm outside this
0:24
window. It's a little bit less reliable in the early window beware of
0:27
ghost infarct core that
0:30
is overestimation of what is actually infarcted based
0:33
on your CBF map that on follow-up turnout
0:36
not to be infarcted.
0:38
Beware of false negative situations that
0:41
can occur very late in acute stroke
0:44
into the Subacute window because that territory
0:47
has already reperfused. So you have normalization or
0:50
even high per perfusion on your
0:53
cvf and and TMax Maps similarly
0:57
beware of bilateral perfusion
1:00
deficit which may mess up the computers
1:03
analysis of what is abnormally reduced
1:06
relatives removable blood volume. So you have to rely on
1:09
your quality of analysis. Okay. This territory is normal. This one
1:12
is abnormal on the ipsilateral side as well.
1:16
Beware of stroke mimics like seizure that
1:19
can be occurring the case of press and several Venus
1:22
thrombosis as we saw in our two cases
1:25
use CTP as a helpful guide to
1:28
augment your review of CT angiography, especially for
1:31
challenging areas, like medium vessel occlusions stenosis
1:34
or in our
1:37
last case Venus thrombosis, which can be easily missed
1:40
on a CT angiogram as well. There are
1:43
emerging uses for CTP for crowded stenosis like
1:46
your case of near occlusion that we had as well as
1:49
for cerebral basis fathom after Hemorrhage about
1:52
caution you to interpret these not in the
1:55
same way that you interpret Lara's vessel occlusions Strokes, right the interpretation
1:58
about the threshold the CBF less than 30 team experience
2:01
doesn't really apply. It's not been validated in
2:04
these clinical contexts. So I would stick to remaining descriptive
2:07
about there these areas of hypo perfusion
2:10
corresponding to the CT angr and Geographic
2:13
and normalities and hopefully
2:16
That's helpful additional data point for the managing neurologists
2:19
neuro-interventional Specialists
2:22
to take to into
2:25
account when determining how to manage these very
2:28
complex patients. So with that having to
2:31
take any questions about the talking general
2:34
or this very last case.
2:36
TTP or TMax which is preferred. Is it
2:39
okay to evaluate only with TTP since some vendors don't
2:42
provide TMax and only give MTT and TTP.
2:49
There's certainly disagreement in the literature about what is
2:52
the best parameter to use the TTP and
2:55
TMax for relatively similar metrics and
2:58
just so happens that the dominant vendors
3:02
at least around my neck of the woods use
3:05
TMax primarily in determining what
3:08
is called the critical hyper
3:11
hypo perfusion Zone, but I
3:14
certainly understand that, you know, the the literature
3:17
is not 100% clear that team expert in
3:20
the six seconds is the best whatsoever in that some
3:23
vendors may choose to use TTP as well. But I
3:26
am agnostic about that. I think there's
3:29
there's
3:32
kind of a general
3:35
preference among these vendors to use team acts and
3:38
that's what I stick to and that's what I'm familiar with.
3:41
Should we always report the hypodensity volume?
3:46
I think that's a stylistic thing. I like
3:49
to do that just because I like to communicate a
3:53
somehow the
3:56
size of infarx and that's
3:59
based on my experience
4:02
of seeing reports that say there's a
4:05
MCA territory infarc, but the infarct is actually like, you know,
4:08
just the basal ganglia plus the insula and just like, you know 10 milliliters
4:11
in Fargo. That's a very different story or the
4:14
patient compared to an MCA in Fargo. That's
4:17
200 milliliters. Right? And so just because
4:20
I like thinking quantitatively I try to estimate the
4:23
area of infarct some people like doing it kind
4:26
of semi quantity large medium small would have you
4:29
but I I if it's easy
4:32
to measure and just takes me a couple seconds once I'm
4:35
fast out with the measuring tools my packs I
4:39
Try to estimate the infarct volume.
4:42
Usually here because we get MRI
4:45
and everybody I usually just provide it
4:48
for volume on the MRI that it's a better a more
4:53
reliable way to measure it than trying to estimate it
4:56
on the first non-con has CT but in
4:59
general, you know, I think there is some relevance
5:03
providing a volume measurement at some
5:06
point because that is correlated with
5:09
their neurologic prognosis.
5:12
Should we exclude a total region on the
5:15
aspect score even if a small part is involved?
5:21
Strictly speaking how the aspects score was defined.
5:24
Yes, if only
5:28
one part of say the
5:31
m6 section of the super ganglionic,
5:34
you know parietal cortex was
5:37
infarcted. Yes, you would say that
5:40
region is affected. It doesn't have to be the whole region is affected.
5:44
Now I want to be clear that to count as affected you
5:47
have to have great white differentiation loss. It's not
5:50
enough to have subtle effacement. It's not enough to
5:53
have a white matter alone hypodensity. Even if
5:56
that's why matter if are you just don't know on non-continent CT
5:59
so you have to see great white differentiation laws
6:02
somewhere in that region to say
6:06
that's affected. But yes any small part
6:09
of that region effective means that the region is affected. So people
6:12
have criticized to aspects score. It's not linearly scaled
6:17
to the infer volume, but this is
6:21
a relatively quick and easy way
6:24
to express the extent of
6:27
MCA territory involved in
6:30
Far That neurologist and neuro
6:33
interventionalists are familiar with